Related Experiment Video
Updated: Apr 1, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
28.1K
Body Mass Index Underestimates Adiposity in Persons With Multiple Sclerosis
Lara A Pilutti1, Robert W Motl1
1Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL.
Archives of Physical Medicine and Rehabilitation
|October 7, 2015
Summary
The standard body mass index (BMI) threshold for obesity underestimates adiposity in individuals with multiple sclerosis (MS). A lower BMI threshold is recommended for accurately assessing obesity in MS populations.
Area of Science:
- Medical research
- Human physiology
- Body composition analysis
Background:
- Body Mass Index (BMI) is a common metric for assessing weight status.
- Accurate assessment of adiposity is crucial for managing health conditions like multiple sclerosis (MS).
- Standard BMI thresholds may not accurately reflect body fat percentage in all populations.
Purpose of the Study:
- To investigate the relationship between BMI and adiposity in individuals with MS and non-MS controls.
- To evaluate the accuracy of current BMI thresholds for identifying obesity in persons with MS.
- To determine optimal BMI thresholds for defining obesity in MS and control groups.
Main Methods:
- Cross-sectional study design.
- Inclusion of 235 individuals with MS and 53 non-MS controls.
- Assessment of body composition using dual-energy x-ray absorptiometry (DXA) to measure percent body fat (%BF).
Main Results:
- Strong associations were found between BMI and %BF in both MS and control groups.
- Standard BMI threshold (30kg/m²) showed high specificity but low sensitivity for detecting obesity in MS.
- Optimal BMI thresholds for identifying %BF-defined obesity were 24.7kg/m² for MS and 25.1kg/m² for controls.
Conclusions:
- A strong correlation exists between BMI and adiposity.
- Current BMI classifications for obesity underestimate true adiposity in individuals with MS.
- Lower BMI thresholds are suggested for more accurate obesity assessment in persons with MS.
More Related Videos
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
386
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
386
Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341

